AVR 5.12% $10.20 anteris technologies ltd

Letter of intent to fund Vacs, page-17

  1. 1,498 Posts.
    lightbulb Created with Sketch. 94
    Questions remain why we were buying a higher stake into the Vaccine business on the back of old CRs which caused the SP farce we are in. That had a detrimental effect on investors and now the U turn.

    Rodne/Wayne come across as politicians who just reverse decisions and not get anything done. Wont be surprised if they start buying back in at a much higher price in a few years time, if the trial outcomes become more positive.

    No accountability or explanations from people like Rodne. I know that new investors see this as very positive news, but its been a sombre affair for ones whose CR money was siphoned few years back.

    Lets face is 60% stake for 18 million is cheap. I think Admedus paid much more than that on the back of our money.

    I was in it more for the vaccines upside than the cardiocel.
    Last edited by pierre77: 27/04/18
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$10.20
Change
-0.550(5.12%)
Mkt cap ! $215.6M
Open High Low Value Volume
$10.73 $10.73 $10.15 $109.7K 10.66K

Buyers (Bids)

No. Vol. Price($)
1 490 $10.19
 

Sellers (Offers)

Price($) Vol. No.
$10.20 911 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.